GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Spago Nanomedical AB (publ) SPAGO.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.04

+21.67%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 437,000

FY2016FY2025

Net income

−SEK 26.6m

FY2016FY2025

Free cash flow

−SEK 56.6m

FY2016FY2025

Shareholders' equity

SEK 30.7m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 437,000SEK 1.9mSEK 1.2mSEK 1.1mSEK 660,000SEK 342,000SEK 30,000SEK 29.6mSEK 47,000SEK 58,000
Research and developmentSEK 11.5mSEK 14.3mSEK 24.5mSEK 17.1mSEK 18.8mSEK 3.3mSEK 2.4mSEK 19.8mSEK 9.2mSEK 3.1m
Operating income−SEK 30.9m−SEK 33.7m−SEK 47.2m−SEK 39.5m−SEK 39.2m−SEK 19.0m−SEK 20.1m−SEK 11.1m−SEK 9.2m−SEK 7.3m
Net income−SEK 26.6m−SEK 32.5m−SEK 42.2m−SEK 39.3m−SEK 39.1m−SEK 18.9m−SEK 20.3m−SEK 11.1m−SEK 9.5m−SEK 7.5m
Diluted earnings per share-0.06-0.09-0.18-0.21-0.47-0.30-0.46-0.31-0.48-0.38

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 36.7mSEK 39.6mSEK 53.0mSEK 206.0mSEK 191.6mSEK 162.8mSEK 140.5mSEK 126.3mSEK 111.6mSEK 80.1m
Cash and short-term investmentsSEK 29.7mSEK 32.5mSEK 45.2mSEK 62.1mSEK 52.5mSEK 28.4mSEK 12.1mSEK 16.5mSEK 30.3mSEK 16.8m
Total liabilitiesSEK 5.9mSEK 6.3mSEK 11.7mSEK 8.8mSEK 6.8mSEK 3.1mSEK 2.9mSEK 4.1mSEK 3.8mSEK 8.2m
Debt—————————SEK 6.0m
Shareholders' equitySEK 30.7mSEK 33.2mSEK 41.3mSEK 197.2mSEK 184.8mSEK 159.7mSEK 137.6mSEK 122.2mSEK 107.8mSEK 71.8m
Shares outstanding454m348m238m190m82m63m44m35m20m20m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 28.3m−SEK 34.7m−SEK 44.9m−SEK 38.2m−SEK 35.6m−SEK 18.8m−SEK 21.3m−SEK 10.5m−SEK 7.7m−SEK 7.9m
Capital spending−SEK 28.3m−SEK 229,000−SEK 153,000−SEK 3.8m−SEK 4.6m−SEK 6.4m−SEK 18.2m−SEK 28.9m−SEK 18.1m−SEK 10.7m
Free cash flow−SEK 56.6m−SEK 34.9m−SEK 45.1m−SEK 42.0m−SEK 40.2m−SEK 25.1m−SEK 39.5m−SEK 39.4m−SEK 25.8m−SEK 18.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue—SEK 22,000SEK 4,000SEK 14,000SEK 81,000SEK 338,000SEK 617,000SEK 485,000
Operating income−SEK 8.4m−SEK 7.9m−SEK 8.9m−SEK 7.4m−SEK 7.1m−SEK 7.5m−SEK 8.1m−SEK 9.1m
Net income−SEK 7.3m−SEK 6.8m−SEK 5.9m−SEK 6.3m−SEK 7.0m−SEK 7.4m−SEK 7.8m−SEK 8.8m
Diluted earnings per share-0.01-0.01-0.01-0.01-0.02-0.02-0.02-0.03
Cash from operations−SEK 5.0m−SEK 3.0m−SEK 6.0m−SEK 7.0m−SEK 8.0m−SEK 6.0m−SEK 7.0m−SEK 7.0m
Capital spending−SEK 5.0m−SEK 3.0m−SEK 6.0m—————
Free cash flow−SEK 10.0m−SEK 6.0m−SEK 12.0m—————
Total assetsSEK 37.7mSEK 30.3mSEK 36.7mSEK 17.2mSEK 23.6mSEK 30.3mSEK 39.6mSEK 47.1m
Cash and short-term investmentsSEK 32.5mSEK 25.9mSEK 29.7mSEK 11.3mSEK 18.5mSEK 26.6mSEK 32.5mSEK 39.9m
Shareholders' equitySEK 31.7mSEK 24.2mSEK 30.7mSEK 12.4mSEK 18.6mSEK 25.6m−SEK 2.24bnSEK 41.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-25.4%5.0%-24.8%
Operating income-7.9%10.2%9.6%
Net income-12.3%7.0%14.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-2750.3%-3285.0%-3735.1%-628.2%
Net margin-2515.5%-3053.1%-3541.5%-591.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-0.8-0.9-0.8-1.2-2.0-5.6-6.0-6.5-3.4-6.4
Price to sales51.415.227.546.2116.5307.1—2.4——

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.